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Background: Emergency Department (ED) patients who present with symptoms that may be due to arrhythmias (ARR), such as palpitations or 
syncope, are often discharged after a negative evaluation and then referred for outpatient cardiac monitoring. This approach is costly and ineffective 
due to poor follow-up, limited monitor recording time, and non-compliance. The prevalence of ARR in this patient population is unclear.
Methods: Between February and October 2011, a novel, single use long-term, continuous recording patch (Zio® Patch - iRhythm Technologies, Inc.) 
was initiated on a convenience sample of ED patients with suspected ARR upon discharge. Patients could wear the Zio® Patch for up to 14 days 
and press the integrated marker button when symptomatic. Devices were mailed back for analysis for any significant ARR defined as: ventricular 
tachycardia (VT), paroxysmal atrial fibrillation (PAF), supraventricular tachycardia (SVT), ≥3 sec pause, 2nd degree Mobitz II or 3rd degree AV Block, 
or symptomatic bradycardia. Descriptive statistics were used for analysis.
Results: 135 patients - 65 males (48%), mean age 48.6 (SD 21.3) - were enrolled and none were lost to follow-up. Palpitations (30%) or syncope 
(18%) were the most common indications. Average device wear time was 6.1 days (SD 3.1; max 14 days). 51 (38%) had ≥1 significant ARR and 7 
were symptomatic at the time. Average time to first ARR episode was 1.8 days (SD 2.2; max 9.8 days) and first symptomatic ARR 2.1 days (SD 3.0; 
max 8.6 days). 44 SVT, 5 PAF, 3 VT, and 1 AV Block were detected. 81 symptomatic patients (60%) did not have any significant ARR.
Conclusions: The prevalence of ARR in discharged ED patients (38%) is significant. Many symptomatic patients (60%) are found to not have ARR. 
Our data suggests that a minimum of ~7 days of ambulatory cardiac monitoring is required to optimize detection in most ED patients. The Zio® 
Patch is a novel, single-use ambulatory cardiac monitor that can be successfully initiated upon ED discharge. Its ease-of-use results in improved 
patient compliance and accurate detection of symptomatic and asymptomatic rhythms over 14 days. Use of the Zio® Patch in the ED may facilitate 
ARR diagnosis and potentially save healthcare costs.
